{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T19:30:45Z","timestamp":1781811045274,"version":"3.54.5"},"reference-count":75,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Head and neck squamous cell carcinomas (HNSCCs) that develop from the mucosal epithelium in the oral cavity, pharynx, and larynx are a heterogeneous group of malignant tumors. A lack of appropriate screening and diagnostic methods leads to late diagnoses, with the majority of patients having locally advanced disease, which is associated with a high risk of local recurrence and a poor prognosis and is usually treated with combination therapies. Biomarkers for predicting the therapy response and risk of recurrence in HNSCC patients are urgently needed. Liquid biopsy, e.g., the profiling of circulating biomarkers in bodily fluids, is a promising approach with increasing utility in the early detection and diagnosis of cancer, monitoring cancer progression, patient stratification and treatment selection, detecting minimal residual disease (MRD), and predicting recurrence across different cancer types, including HNSCC. Among liquid biomarkers, circulating tumor DNA (ctDNA), which is based on detecting tumor-specific mutations, insertions\/deletions, copy number alterations, and methylation, is the most promising transformative tool in cancer management and personalized cancer treatment. In this review, we provide an update of recent data on the role of non-viral ctDNA in the management of HNSCC patients. Accumulating data suggests the enormous potential of ctDNA profiling by serial sampling during and after definitive therapy in detecting MRD and predicting recurrence in HNSSC patients treated with a single treatment modality (surgery or radiotherapy) or with combination therapies, including immune-checkpoint-inhibitor-based immunotherapy. By incorporating the latest immunotherapy trials and organizing the data by the treatment modality, this review offers a novel perspective not found in previous surveys.<\/jats:p>","DOI":"10.3390\/cancers17142279","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:38:27Z","timestamp":1752140307000},"page":"2279","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Narrative Review of the Role of Non-Viral Circulating Tumor DNA Profiling in Predicting the Treatment Response and Recurrence in Head and Neck Squamous Cell Carcinoma"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8471-5254","authenticated-orcid":false,"given":"Ugur","family":"Gezer","sequence":"first","affiliation":[{"name":"Department of Basic Oncology, Oncology Institute, Istanbul University, 34093 Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4921-6975","authenticated-orcid":false,"given":"Rasim","family":"Meral","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Oncology Institute, Istanbul University, 34093 Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4995-4759","authenticated-orcid":false,"given":"Emre","family":"\u00d6zg\u00fcr","sequence":"additional","affiliation":[{"name":"Department of Basic Oncology, Oncology Institute, Istanbul University, 34093 Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru. E.","family":"Y\u00f6r\u00fcker","sequence":"additional","affiliation":[{"name":"Department of Basic Oncology, Oncology Institute, Istanbul University, 34093 Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Bronkhorst","sequence":"additional","affiliation":[{"name":"Institute of Laboratory Medicine, TUM University Hospital Munich, German Heart Center, 80636 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9210-7064","authenticated-orcid":false,"given":"Stefan","family":"Holdenrieder","sequence":"additional","affiliation":[{"name":"Institute of Laboratory Medicine, TUM University Hospital Munich, German Heart Center, 80636 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.coms.2014.01.001","article-title":"Epidemiologic trends in head and neck cancer and aids in diagnosis","volume":"26","author":"Vigneswaran","year":"2014","journal-title":"Oral Maxillofac. Surg. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Economopoulou, P., de Bree, R., Kotsantis, I., and Psyrri, A. (2019). Diagnostic tumor markers in head and neck squamous cell carcinoma (HNSCC) in the clinical setting. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00827"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Lo, T., Wang, C., Chen, C., Yang, T., Lou, P., Ko, J., Chang, Y.L., and Chen, T.C. (2022). Diagnostic performance of core needle biopsy for nodal recurrences in patients with head and neck squamous cell carcinoma. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-06102-0"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(08)60728-X","article-title":"Head and neck cancer","volume":"371","author":"Argiris","year":"2008","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev.pathol.4.110807.092158","article-title":"Molecular pathology of head and neck cancer: Implications for diagnosis, prognosis, and treatment","volume":"4","author":"Pai","year":"2009","journal-title":"Annu. Rev. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.6004\/jnccn.2014.0142","article-title":"Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology","volume":"12","author":"Pfister","year":"2014","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_8","first-page":"560","article-title":"Challenges with the 8th edition of the AJCC cancer staging manual for breast, testicular, and head and neck cancers","volume":"17","author":"Sahin","year":"2019","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Wang, H., Zheng, Z., Zhang, Y., Bian, C., Bao, J., Xin, Y., and Jiang, X. (2023). Locally advanced head and neck squamous cell carcinoma treatment efficacy and safety: A systematic review and network meta-analysis. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1269863"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.acr.2021.05.002","article-title":"Head and neck cancer: Current challenges and future perspectives","volume":"152","author":"Bhat","year":"2021","journal-title":"Adv. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41431-018-0132-4","article-title":"Circulating cell-free nucleic acids: Characteristics and applications","volume":"26","author":"Szemes","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"8062","DOI":"10.3390\/ijms21218062","article-title":"Putative origins of cell-free DNA in humans: A review of active and passive nucleic acid release mechanisms","volume":"21","author":"Grabuschnig","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"13219","DOI":"10.3390\/ijms241713219","article-title":"Using cfDNA and ctDNA as oncologic markers: A path to clinical validation","volume":"24","author":"Dao","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10555-017-9685-x","article-title":"Tumor DNA: An emerging biomarker in head and neck cancer","volume":"36","author":"Bellairs","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients","volume":"11","author":"Schwarzenbach","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/s41416-023-02398-5","article-title":"Redefining precision radiotherapy through liquid biopsy","volume":"129","author":"McLaren","year":"2023","journal-title":"Br. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Telekes, A., and Horv\u00e1th, A. (2022). The Role of Cell-Free DNA in Cancer Treatment Decision Making. Cancers, 14.","DOI":"10.3390\/cancers14246115"},{"key":"ref_18","first-page":"201","article-title":"The changing face of circulating tumor DNA (ctDNA) profiling: Factors that shape the landscape of methodologies, technologies, and commercialization","volume":"35","author":"Bronkhorst","year":"2023","journal-title":"Med. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Aulakh, S., Silverman, D., Young, K., Dennis, S., and Birkeland, A. (2022). The Promise of Circulating Tumor DNA in Head and Neck Cancer. Cancers, 14.","DOI":"10.3390\/cancers14122968"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41591-022-02115-4","article-title":"Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer","volume":"29","author":"Kotani","year":"2023","journal-title":"Nat. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"105805","DOI":"10.1016\/j.oraloncology.2022.105805","article-title":"Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer","volume":"128","author":"Mattox","year":"2022","journal-title":"Oral Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Nassar, S.I., Suk, A., Nguyen, S.A., Adilbay, D., Pang, J., and Nathan, C.O. (2024). The Role of ctDNA and Liquid Biopsy in the Diagnosis and Monitoring of Head and Neck Cancer: Towards Precision Medicine. Cancers, 16.","DOI":"10.20944\/preprints202408.1590.v1"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Silvoniemi, A., Laine, J., Aro, K., Nissi, L., B\u00e4ck, L., Schildt, J., Hirvonen, J., Hagstr\u00f6m, J., Irjala, H., and Aaltonen, L.M. (2023). Circulating tumor DNA in head and neck squamous cell carcinoma: Association with Metabolic Tumor Burden Determined with FDG-PET\/CT. Cancers, 15.","DOI":"10.3390\/cancers15153970"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1002\/jcb.25592","article-title":"TP53 Mutations in head and neck squamous cell carcinoma and their impact on disease progression and treatment response","volume":"117","author":"Zhou","year":"2016","journal-title":"J. Cell. Biochem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1002\/onco.13573","article-title":"The Prognostic and therapeutic value of the mutational profile of blood and tumor tissue in head and neck squamous cell carcinoma","volume":"26","author":"Wilson","year":"2021","journal-title":"Oncologist"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"van Ginkel, J.H., Huibers, M.M.H., van Es, R.J.J., de Bree, R., and Willems, S.M. (2017). Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3424-0"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Kampel, L., Feldstein, S., Tsuriel, S., Hannes, V., Neiderman, C., Horowitz, G., Warshavsky, A., Leider-Trejo, L., Hershkovitz, D., and Muhanna, N. (2023). Mutated TP53 in circulating tumor DNA as a risk level biomarker in head and neck squamous cell carcinoma patients. Biomolecules, 13.","DOI":"10.3390\/biom13091418"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.21037\/tcr-23-878","article-title":"Predicting therapeutic responses in head and neck squamous cell carcinoma from TP53 mutation detected by cell-free DNA","volume":"12","author":"Wei","year":"2023","journal-title":"Transl. Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"104631","DOI":"10.1016\/j.oraloncology.2020.104631","article-title":"Liquid biopsy for mutational profiling of locoregional recurrent and\/or metastatic head and neck squamous cell carcinoma","volume":"104","author":"Galot","year":"2020","journal-title":"Oral Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.21037\/tcr.2019.12.70","article-title":"Next generation sequencing of cell free circulating tumor DNA in blood samples of recurrent and metastatic head and neck cancer patients","volume":"9","author":"Porter","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Payne, K.F.B., Brotherwood, P., Suriyanarayanan, H., Brooks, J.M., Batis, N., Beggs, A.D., Gendoo, D.M.A., Mehanna, H., and Nankivell, P. (2024). Circulating tumour DNA detects somatic variants contributing to spatial and temporal intra-tumoural heterogeneity in head and neck squamous cell carcinoma. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1374816"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"107011","DOI":"10.1016\/j.oraloncology.2024.107011","article-title":"Exploring the impact of intra-tumoural heterogeneity on liquid biopsy cell-free DNA methylation and copy number in head and neck squamous cell carcinoma","volume":"158","author":"Payne","year":"2024","journal-title":"Oral Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.21873\/cdp.10254","article-title":"Circulating plasma cell-free DNA (cfDNA) as a predictive biomarker for radiotherapy: Results from a prospective trial in head and neck cancer","volume":"3","author":"Koukourakis","year":"2023","journal-title":"Cancer Diagn. Progn."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/s41416-022-01716-7","article-title":"Liquid BIOpsy for MiNimal RESidual DiSease detection in head and meck squamous cell carcinoma (LIONESS)\u2013a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma","volume":"126","author":"Flach","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"107111","DOI":"10.1016\/j.oraloncology.2024.107111","article-title":"Deciphering molecular relapse and intra-tumor heterogeneity in non-metastatic resectable head and neck squamous cell carcinoma using circulating tumor DNA","volume":"160","author":"Marret","year":"2025","journal-title":"Oral Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3857\/roj.2022.00444","article-title":"Liquid biopsy using cfDNA to predict radiation therapy response in solid tumors","volume":"41","author":"Cho","year":"2023","journal-title":"Radiat. Oncol. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ijc.35152","article-title":"Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re-radiotherapy","volume":"156","author":"Janke","year":"2025","journal-title":"Int. J. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/ohn.760","article-title":"ctDNA as an Adjunct to Posttreatment PET for Head and Neck Cancer Recurrence Risk Assessment","volume":"171","author":"Lele","year":"2024","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"110364","DOI":"10.1016\/j.radonc.2024.110364","article-title":"Longitudinal cell-free DNA characterization by low-coverage whole-genome sequencing in patients undergoing high-dose radiotherapy","volume":"197","author":"Balermpas","year":"2024","journal-title":"Radiother. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1158\/1078-0432.CCR-21-0110","article-title":"Tumor-na\u00efve multimodal profiling of circulating tumor DNA in head and neck squamous cell carcinoma","volume":"27","author":"Burgener","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ijrobp.2024.01.078","article-title":"Can circulating tumor DNA be utilized as a marker to guide high-risk head and neck squamous cell patients treatment?","volume":"18","author":"Orland","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Chikuie, N., Urabe, Y., Ueda, T., Hamamoto, T., Taruya, T., Kono, T., Yumii, K., and Takeno, S. (2022). Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-13417-5"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.radonc.2020.07.027","article-title":"Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapy","volume":"151","author":"Hilke","year":"2020","journal-title":"Radiother. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41418-024-01272-y","article-title":"Multimodal detection of molecular residual disease in high-risk locally advanced squamous cell carcinoma of the head and neck","volume":"31","author":"Zou","year":"2024","journal-title":"Cell Death Differ."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1002\/cam4.4726","article-title":"Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma","volume":"11","author":"Kogo","year":"2022","journal-title":"Cancer Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1158\/1078-0432.CCR-24-0590","article-title":"Personalized ctDNA for monitoring disease status in head and neck squamous cell carcinoma","volume":"30","author":"Hanna","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"113372","DOI":"10.1016\/j.ejca.2023.113372","article-title":"Tumour-agnostic plasma assay for circulating tumour DNA predicts outcome in recurrent and\/or metastatic squamous cell carcinoma of the head and neck treated with a PD-1 inhibitor","volume":"195","author":"Dietz","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"8902","DOI":"10.3390\/curroncol30100643","article-title":"Next-generation sequencing analysis of mutations in circulating tumor DNA from the plasma of patients with head-neck cancer undergoing chemo-radiotherapy using a pan-cancer cell-free assay","volume":"30","author":"Koukourakis","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/ijms26010235","article-title":"Dynamic changes in circulating tumor DNA during immunotherapy for head and neck cancer: SHIZUKU-HN study","volume":"26","author":"Noji","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejca.2023.04.014","article-title":"Circulating tumour DNA kinetics in recurrent\/metastatic head and neck squamous cell cancer patients","volume":"188","author":"Taylor","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/hed.27515","article-title":"It is time to improve the diagnostic workup of oropharyngeal cancer with circulating tumor HPV DNA: Systematic review and meta-analysis","volume":"45","author":"Paolini","year":"2023","journal-title":"Head Neck"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13046-024-03137-1","article-title":"The landscape of circulating tumor HPV DNA and TTMV-HPV DNA for surveillance of HPV-oropharyngeal carcinoma: Systematic review and meta-analysis","volume":"43","author":"Campo","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jdsr.2023.08.004","article-title":"Liquid biopsies based on cell-free DNA as a potential biomarker in head and neck cancer","volume":"59","year":"2023","journal-title":"Jpn. Dent. Sci. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/jamaoto.2024.1067","article-title":"Accuracy of salivary circulating tumor human papillomavirus DNA in detecting oropharyngeal cancer: A systematic review and meta-analysis","volume":"150","author":"Lakshmipathy","year":"2024","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.21037\/cco.2016.03.07","article-title":"Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma","volume":"5","author":"Fung","year":"2016","journal-title":"Chin. Clin. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-0716-0904-0_9","article-title":"Epstein-Barr virus DNA in nasopharyngeal carcinoma: A brief review","volume":"2204","author":"Xue","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.annonc.2022.05.520","article-title":"ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: A report from the ESMO Precision Medicine Working Group","volume":"33","author":"Pascual","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.annonc.2023.10.693","article-title":"Circulating tumour DNA for detection of minimal residual disease in head and neck squamous cell carcinoma: A new hope","volume":"34","author":"Lam","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1200\/JCO.19.02444","article-title":"Plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV-associated oropharyngeal cancer","volume":"38","author":"Chera","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/path.5249","article-title":"Plasma Epstein-Barr virus DNA as an archetypal circulating tumour DNA marker","volume":"247","author":"Lam","year":"2019","journal-title":"J. Pathol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/cncr.21324","article-title":"The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence-based clinical guidelines","volume":"104","author":"Delaney","year":"2005","journal-title":"Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.annonc.2020.07.011","article-title":"Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS\u2013ESMO\u2013ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Machiels","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1053\/j.seminoncol.2004.09.003","article-title":"Reirradiation of recurrent head and neck cancers with curative intent","volume":"31","author":"Chmura","year":"2004","journal-title":"Semin. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11547-023-01713-7","article-title":"Reirradiation of head and neck squamous cell carcinomas: A pragmatic approach-part I: Prognostic factors and indications to treatment","volume":"129","author":"Alterio","year":"2024","journal-title":"Radiol. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hed.20697","article-title":"Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck","volume":"30","author":"Spencer","year":"2008","journal-title":"Head Neck"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"x173","DOI":"10.1093\/annonc\/mds299","article-title":"Treatment choice for locally advanced head and neck cancers on the basis of risk factors: Biological risk factors","volume":"23","author":"Braakhuis","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.annonc.2023.09.3102","article-title":"Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck","volume":"34","author":"Galot","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1158\/2159-8290.CD-20-1680","article-title":"The next decade of immune checkpoint therapy","volume":"11","author":"Sharma","year":"2021","journal-title":"Cancer Discov."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"101977","DOI":"10.1016\/j.ctrv.2020.101977","article-title":"Biomarkers for immunotherapy response in head and neck cancer","volume":"84","author":"Gavrielatou","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e003476","DOI":"10.1136\/jitc-2021-003476","article-title":"Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study","volume":"9","author":"Oliva","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Wang, H., Zhou, F., Qiao, M., Li, X., Zhao, C., Cheng, L., Chen, X., and Zhou, C. (2021). The role of circulating tumor DNA in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A aystematic review and Meta-Analysis. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.671874"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e005854","DOI":"10.1136\/jitc-2022-005854","article-title":"Changes in circulating tumor DNA and outcomes in solid tumors treated with immune checkpoint inhibitors: A systematic review","volume":"11","author":"Wilson","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Jiang, R., Cheng, X., Li, P., Meng, E., Wu, X., and Wu, H. (2024). Plasma circulating tumor DNA unveils the efficacy of PD-1 inhibitors and chemotherapy in advanced gastric cancer. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-63486-x"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/14\/2279\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:06:57Z","timestamp":1760033217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/14\/2279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":75,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["cancers17142279"],"URL":"https:\/\/doi.org\/10.3390\/cancers17142279","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]}}}